These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 14313506)
1. LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES. KIBLER RF Ann N Y Acad Sci; 1965 Mar; 122():469-79. PubMed ID: 14313506 [No Abstract] [Full Text] [Related]
2. Experimental allergic encephalomyelitis, spontaneous demyelinating disease and multiple sclerosis. STEINER G Gaz Med Port; 1951; 4(3):824-34. PubMed ID: 14897125 [No Abstract] [Full Text] [Related]
4. Experimental allergic encephalomyelitis. A review. Rowe MJ Bull Los Angeles Neurol Soc; 1969 Jan; 34(1):55-66. PubMed ID: 4974423 [No Abstract] [Full Text] [Related]
5. INTRODUCTORY REMARKS: SUPPRESSION OF DEMYELINATING DISEASE. KIBLER RF Ann N Y Acad Sci; 1965 Mar; 122():332. PubMed ID: 14313492 [No Abstract] [Full Text] [Related]
6. [STUDIES ON THE DOSE-EFFECT RELATIONSHIP OF VARIOUS CORTICOSTEROID DERIVATIVES]. MATHIES H; HEINSIUS M; RASPE J Med Klin; 1964 Jun; 59():935-9. PubMed ID: 14234233 [No Abstract] [Full Text] [Related]
8. Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis. Dokoohaki S; Ghareghani M; Ghanbari A; Farhadi N; Zibara K; Sadeghi H Steroids; 2017 Dec; 128():32-36. PubMed ID: 29061489 [TBL] [Abstract][Full Text] [Related]
9. Experimental allergic encephalomyelitis: a light and electron microscope study of remyelination and "sclerosis" in vitro. Raine CS; Bornstein MB J Neuropathol Exp Neurol; 1970 Oct; 29(4):552-74. PubMed ID: 5471921 [No Abstract] [Full Text] [Related]
10. [Immuno-allergic significance of perivascular cellular infiltrates in human primary demyelinating encephalomyelitis]. Duma D; Papilian VV; Serban M; Popovici L Neurol Psihiatr Neurochir; 1965; 10(4):349-57. PubMed ID: 5864369 [No Abstract] [Full Text] [Related]
11. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system. Prineas J; Raine CS; Wísniewski H Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782 [No Abstract] [Full Text] [Related]
12. Adrenal steroid therapy in neurological disease. Part I. Eisen AA; Norris JW Can Med Assoc J; 1969 Jan; 100(1):27-30. PubMed ID: 4388115 [No Abstract] [Full Text] [Related]
14. Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis sera. Johnson AB; Bornstein MB Brain Res; 1978 Dec; 159(1):173-82. PubMed ID: 83176 [No Abstract] [Full Text] [Related]
15. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY]. POLANO MK Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860 [No Abstract] [Full Text] [Related]
16. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Lassmann H Schriftenr Neurol; 1983; 25():1-135. PubMed ID: 6605578 [No Abstract] [Full Text] [Related]
17. USE OF AN ORAL CORTICOSTEROID IN THE TREATMENT OF MULTIPLE SCLEROSIS; A DOUBLE-BLIND STUDY. TOURTELLOTTE WW; HAERER AF Arch Neurol; 1965 May; 12():536-45. PubMed ID: 14288990 [No Abstract] [Full Text] [Related]
18. FUNCTIONAL STUDIES OF CULTURED BRAIN TISSUES AS RELATED TO "DEMYELINATIVE DISORDERS". BORNSTEIN MB; CRAIN SM Science; 1965 May; 148(3674):1242-4. PubMed ID: 14280011 [TBL] [Abstract][Full Text] [Related]
19. Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis. Shu YQ; Yang Y; Wang YG; Dai YQ; Xiao L; Qiu W; Lu ZQ; Wu AM; Ruan HF; Hu XQ Chin Med J (Engl); 2013; 126(18):3439-45. PubMed ID: 24034086 [TBL] [Abstract][Full Text] [Related]
20. Chronic experimental allergic encephalomyelitis induced in rabbits with bovine white matter proteolipid apoprotein. Williams RM; Lees MB; Cambi F; Macklin WB J Neuropathol Exp Neurol; 1982 Sep; 41(5):508-21. PubMed ID: 7108565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]